Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 68

1.

Probiotics and immunity.

Borchers AT, Selmi C, Meyers FJ, Keen CL, Gershwin ME.

J Gastroenterol. 2009;44(1):26-46. doi: 10.1007/s00535-008-2296-0. Epub 2009 Jan 22. Review.

PMID:
19159071
2.

T cell transfer model of chronic colitis: concepts, considerations, and tricks of the trade.

Ostanin DV, Bao J, Koboziev I, Gray L, Robinson-Jackson SA, Kosloski-Davidson M, Price VH, Grisham MB.

Am J Physiol Gastrointest Liver Physiol. 2009 Feb;296(2):G135-46. doi: 10.1152/ajpgi.90462.2008. Epub 2008 Nov 25. Review.

3.

The transcription factor IFN regulatory factor-4 controls experimental colitis in mice via T cell-derived IL-6.

Mudter J, Amoussina L, Schenk M, Yu J, Brüstle A, Weigmann B, Atreya R, Wirtz S, Becker C, Hoffman A, Atreya I, Biesterfeld S, Galle PR, Lehr HA, Rose-John S, Mueller C, Lohoff M, Neurath MF.

J Clin Invest. 2008 Jul;118(7):2415-26. doi: 10.1172/JCI33227.

4.
5.

Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells.

Pronio A, Montesani C, Butteroni C, Vecchione S, Mumolo G, Vestri A, Vitolo D, Boirivant M.

Inflamm Bowel Dis. 2008 May;14(5):662-8. doi: 10.1002/ibd.20369.

PMID:
18240282
6.
7.

Therapeutic strategies for targeting the IL-6/STAT3 cytokine signaling pathway in inflammatory bowel disease.

Mitsuyama K, Matsumoto S, Masuda J, Yamasakii H, Kuwaki K, Takedatsu H, Sata M.

Anticancer Res. 2007 Nov-Dec;27(6A):3749-56. Review.

8.

A comparative study of the preventative effects exerted by three probiotics, Bifidobacterium lactis, Lactobacillus casei and Lactobacillus acidophilus, in the TNBS model of rat colitis.

Peran L, Camuesco D, Comalada M, Bailon E, Henriksson A, Xaus J, Zarzuelo A, Galvez J.

J Appl Microbiol. 2007 Oct;103(4):836-44.

9.

Anti-inflammatory and side effects of cyclooxygenase inhibitors.

Süleyman H, Demircan B, Karagöz Y.

Pharmacol Rep. 2007 May-Jun;59(3):247-58. Review.

10.

Il-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance.

Mudter J, Neurath MF.

Inflamm Bowel Dis. 2007 Aug;13(8):1016-23. Review.

PMID:
17476678
11.

Probiotic effects on inflammatory bowel disease.

Sheil B, Shanahan F, O'Mahony L.

J Nutr. 2007 Mar;137(3 Suppl 2):819S-24S. Review.

12.

Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation.

Kim N, Kunisawa J, Kweon MN, Eog Ji G, Kiyono H.

Clin Immunol. 2007 Apr;123(1):30-9. Epub 2007 Jan 10. Erratum in: Clin Immunol.2007 Sep;124(3):354.

PMID:
17218154
13.

Expression and functional characterization of FOXP3+ CD4+ regulatory T cells in ulcerative colitis.

Yu QT, Saruta M, Avanesyan A, Fleshner PR, Banham AH, Papadakis KA.

Inflamm Bowel Dis. 2007 Feb;13(2):191-9.

PMID:
17206665
14.

Healing impairment effect of cyclooxygenase inhibitors on dextran sulfate sodium-induced colitis in rats.

Tsubouchi R, Hayashi S, Aoi Y, Nishio H, Terashima S, Kato S, Takeuchi K.

Digestion. 2006;74(2):91-100. Epub 2006 Dec 1.

PMID:
17143008
15.

Interleukin-6 trans-signaling in inflammatory bowel disease.

Mitsuyama K, Sata M, Rose-John S.

Cytokine Growth Factor Rev. 2006 Dec;17(6):451-61. Epub 2006 Oct 12. Review.

PMID:
17045835
16.

COX-2: a pivotal enzyme in mucosal protection and resolution of inflammation.

Wallace JL.

ScientificWorldJournal. 2006 May 25;6:577-88. Review.

17.

STAT3 activation via interleukin 6 trans-signalling contributes to ileitis in SAMP1/Yit mice.

Mitsuyama K, Matsumoto S, Rose-John S, Suzuki A, Hara T, Tomiyasu N, Handa K, Tsuruta O, Funabashi H, Scheller J, Toyonaga A, Sata M.

Gut. 2006 Sep;55(9):1263-9. Epub 2006 May 8.

18.

Regulation of apoptosis during homeostasis and disease in the intestinal epithelium.

Edelblum KL, Yan F, Yamaoka T, Polk DB.

Inflamm Bowel Dis. 2006 May;12(5):413-24. Review.

PMID:
16670531
19.

Toll-like receptor 2 controls expansion and function of regulatory T cells.

Sutmuller RP, den Brok MH, Kramer M, Bennink EJ, Toonen LW, Kullberg BJ, Joosten LA, Akira S, Netea MG, Adema GJ.

J Clin Invest. 2006 Feb;116(2):485-94. Epub 2006 Jan 19.

20.

The biology of p38 kinase: a central role in inflammation.

Schieven GL.

Curr Top Med Chem. 2005;5(10):921-8. Review.

PMID:
16178737

Supplemental Content

Support Center